LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.031623
 49.63 27.76 1368 4818 0.2839 0.6886
MN20160318_Q01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
 51.33 27.76 908 5117 0.1775 0.5895
MN20160318_Q01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
 51.33 27.76 926 5117 0.1810 0.5936
MN20160318_Q01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
 51.33 27.76 193 5117 0.0377 0.2939
MN20160318_Q01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
 51.33 27.76 1416 5117 0.2767 0.6862
MN20160318_Q01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
 53.04 27.76 954 5365 0.1778 0.5932
MN20160318_Q01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
 53.04 27.76 970 5365 0.1808 0.5967
MN20160318_Q01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
 53.04 27.76 213 5365 0.0397 0.3078
MN20160318_Q01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
 53.04 27.76 1400 5365 0.2609 0.6757
MN20160318_Q01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
 54.74 27.76 966 5606 0.1723 0.5897
MN20160318_Q01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
 54.74 27.76 983 5606 0.1753 0.5933
MN20160318_Q01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
 54.74 27.76 229 5606 0.0408 0.3173
MN20160318_Q01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
 54.74 27.76 1452 5606 0.2590 0.6765
MN20160318_Q01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
 56.45 27.76 989 5745 0.1721 0.5911
MN20160318_Q01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
 56.45 27.76 1009 5745 0.1756 0.5953
MN20160318_Q01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
 56.45 27.76 238 5745 0.0414 0.3222
MN20160318_Q01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
 56.45 27.76 1477 5745 0.2571 0.6763
MN20160318_Q01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
 58.15 27.76 1005 5906 0.1702 0.5906
MN20160318_Q01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
 58.15 27.76 1027 5906 0.1739 0.5951
MN20160318_Q01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
 58.15 27.76 240 5906 0.0406 0.3217
MN20160318_Q01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
 58.15 27.76 1501 5906 0.2541 0.6753
MN20160318_Q01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
 59.85 27.76 996 6062 0.1643 0.5852
MN20160318_Q01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
 59.85 27.76 1011 6062 0.1668 0.5883
MN20160318_Q01
D07
MCF 10A-H2B-mCherry Trametinib
0.031623
 59.85 27.76 248 6062 0.0409 0.3255
MN20160318_Q01
L22
MCF 10A-H2B-mCherry Trametinib
0.031623
 59.85 27.76 1487 6062 0.2453 0.6691
MN20160318_Q01
L22